Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03416335
Title A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

lung non-small cell carcinoma

stomach cancer

melanoma

cervical cancer

hepatocellular carcinoma

Advanced Solid Tumor

Merkel cell carcinoma

head and neck squamous cell carcinoma

transitional cell carcinoma

Therapies

DSP-0509

DSP-0509 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Health Melvin and Bren Simon Cancer Center Active, not recruiting Indianapolis Indiana 46202 United States Details
University of North Carolina at Chapel Hill Recruiting Chapel Hill North Carolina 25799 United States Details
Fox Chase Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
Henry-Joyce Cancer Center, Vanderbilt University Recruiting Nashville Tennessee 37232 United States Details
M.D. Anderson Cancer Center, The University of Texas Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field